🚀 VC round data is live in beta, check it out!
Wandong Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Wandong Medical and similar public comparables like Enovis, Savaria, AtriCure, Nihon Kohden and more.
Wandong Medical Overview
About Wandong Medical
Beijing Wandong Medical Technology Co Ltd is engaged in the development, manufacture, and distribution of medical equipment. Its products consist of radiological imaging equipment, including angiographic and cardiac systems, digital direct radiography (DR) imaging equipment, high frequency diagnostic systems, high frequency radiographic systems, conventional x-ray diagnostic equipment and high frequency mobile units, magnetic resonance imaging (MRI) equipment, as well as digital medical image management systems, among others. The company is also engaged in providing maintenance services.
Founded
1997
HQ
Employees
964
Website
Financials (FY)
EV
$1B
Wandong Medical Financials
Wandong Medical reported last fiscal year revenue of $197M and negative EBITDA of ($37M).
In the same fiscal year, Wandong Medical generated $52M in gross profit, ($37M) in EBITDA losses, and had net loss of ($33M).
Revenue (LTM)
Wandong Medical P&L
In the most recent fiscal year, Wandong Medical reported revenue of $197M and EBITDA of ($37M).
Wandong Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $197M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $52M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 27% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($37M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (19%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (20%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($33M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (17%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Wandong Medical Stock Performance
Wandong Medical has current market cap of $2B, and enterprise value of $1B.
Market Cap Evolution
Wandong Medical's stock price is $2.16.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $2B | 0.0% | XXX | XXX | XXX | $-0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialWandong Medical Valuation Multiples
Wandong Medical trades at 5.3x EV/Revenue multiple, and (28.1x) EV/EBITDA.
EV / Revenue (LTM)
Wandong Medical Financial Valuation Multiples
As of April 19, 2026, Wandong Medical has market cap of $2B and EV of $1B.
Equity research analysts estimate Wandong Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Wandong Medical has a P/E ratio of (45.5x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 5.3x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (28.1x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (26.1x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 19.9x | XXX | XXX | XXX |
| P/E | — | XXX | (45.5x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (20.3x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Wandong Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Wandong Medical Margins & Growth Rates
Wandong Medical's revenue in the last fiscal year declined by (12%).
Wandong Medical's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Wandong Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (12%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (19%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (222%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 6% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 20% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 47% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Wandong Medical Public Comps
See public comps and valuation multiples for other Medical Devices and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Wandong Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Enovis | XXX | XXX | XXX | XXX | XXX | XXX |
| Savaria | XXX | XXX | XXX | XXX | XXX | XXX |
| AtriCure | XXX | XXX | XXX | XXX | XXX | XXX |
| Nihon Kohden | XXX | XXX | XXX | XXX | XXX | XXX |
| Haier Biomedical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Wandong Medical M&A Activity
Wandong Medical acquired XXX companies to date.
Last acquisition by Wandong Medical was on XXXXXXXX, XXXXX. Wandong Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Wandong Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialWandong Medical Investment Activity
Wandong Medical invested in XXX companies to date.
Wandong Medical made its latest investment on XXXXXXXX, XXXXX. Wandong Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Wandong Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Wandong Medical
| When was Wandong Medical founded? | Wandong Medical was founded in 1997. |
| Where is Wandong Medical headquartered? | Wandong Medical is headquartered in China. |
| How many employees does Wandong Medical have? | As of today, Wandong Medical has over 964 employees. |
| Is Wandong Medical publicly listed? | Yes, Wandong Medical is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of Wandong Medical? | Wandong Medical trades under 600055 ticker. |
| When did Wandong Medical go public? | Wandong Medical went public in 1997. |
| Who are competitors of Wandong Medical? | Wandong Medical main competitors are Enovis, Savaria, AtriCure, Nihon Kohden. |
| What is the current market cap of Wandong Medical? | Wandong Medical's current market cap is $2B. |
| What is the current revenue of Wandong Medical? | Wandong Medical's last fiscal year revenue is $197M. |
| What is the current EV/Revenue multiple of Wandong Medical? | Current revenue multiple of Wandong Medical is 5.3x. |
| Is Wandong Medical profitable? | No, Wandong Medical is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.